药物联合催眠疗法对持续躯体形式疼痛障碍的疗效分析

Hypnotic drugs in combination therapy for sustained efficacy of somatoform pain disorder

目的:探讨抗抑郁药物联合集体催眠疗法对持续躯体形式疼痛障碍的疗效。方法:选取62例符合ICD-10中持续躯体形式疼痛障碍诊断标准的患者,分别给予文拉法辛联合催眠治疗(简称心理组)及单用文拉法辛治疗(简称药物组),分别比较两组治疗前及治疗后2、4、6周疗效,研究用疼痛量表(MOSPM)、汉密尔顿抑郁量表17项(HAMD17)的评分,以减分率及有效率为评定指标。结果:治疗后4周心理组有效率46.8%,治疗后6周两组有效率基本相当;治疗结束时心理组HAMD总分及认知因子分明显低于药物组(P<0.05),治疗后2、4、6周心理组MOSPM总分明显低于药物组(P<0.05),而疼痛严重程度因子分在治疗后4、6周明显低于药物组(P<0.05)。结论:抗抑郁药物联合集体催眠治疗能更迅速缓解持续躯体形式疼痛障碍,并获得良好疗效。

Objective：Objective of antidepressant therapy on the joint collective hypnosis continued somatoform pain disorder.Methods：Selected 62 patients with ICD-10 found in the persistent somatoform pain disorder diagnostic criteria with a,were given Venlafaxine combined hypnosis therapy（referred to as mental group） and single therapy with venlafaxine（the drug group）,two groups were compared before and after the treatment efficacy research 2,4,6 week pain scale（MOSPM）.Hamilton Depression Scale 17（HAMD17） score of,to the reduced rate and effective rate were recorded.Results： 4 weeks after treatment of psychological group effective rate was 46.8%,6 weeks after treatment,the efficiency of the two groups are roughly equal;at the end of psychological group therapy and cognitive factor scores of HAMD total score was significantly lower than the drug group（P〈0.05）,2,4,6 weeks after treatment,mental group was significantly lower than the drug group MOSPM total score（P〈0.05）,the factor scores of pain severity 4,6 weeks after treatment was significantly lower than the drug group（P〈0.05）.Conclusion：Antidepressants combined group hypnosis therapy more quickly relieve the continuing somatoform pain disorder,and achieved good effect.